Your browser doesn't support javascript.
loading
Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy.
Lu, Yilei; Wang, Siqi; Wang, Yuhang; Li, Mingshan; Liu, Yili; Xue, Dongwei.
Afiliación
  • Lu Y; Department of Urology, The Forth Hospital of China Medical University, Shenyang, China.
  • Wang S; Department of Urology, The Forth Hospital of China Medical University, Shenyang, China.
  • Wang Y; Department of Urology, The Forth Hospital of China Medical University, Shenyang, China.
  • Li M; Department of Urology, The Forth Hospital of China Medical University, Shenyang, China.
  • Liu Y; Department of Urology, The Forth Hospital of China Medical University, Shenyang, China.
  • Xue D; Department of Urology, The Forth Hospital of China Medical University, Shenyang, China.
Front Oncol ; 12: 879828, 2022.
Article en En | MEDLINE | ID: mdl-35720013
Bladder cancer is one of the most common malignant tumors in urinary system. Intravesical chemotherapy is a common adjuvant therapy after transurethral resection of bladder tumors. However, it has several disadvantages such as low drug penetration rate, short residence time, unsustainable action and inability to release slowly, thus new drug delivery and new modalities in delivery carriers need to be continuously explored. Nano-drug delivery system is a novel way in treatment for bladder cancer that can increase the absorption rate and prolong the duration of drug, as well as sustain the action by controlling drug release. Currently, nano-drug delivery carriers mainly included liposomes, polymers, and inorganic materials. In this paper, we reveal current researches in nano-drug delivery system in bladder cancer intravesical chemotherapy by describing the applications and defects of liposomes, polymers and inorganic material nanocarriers, and provide a basis for the improvement of intravesical chemotherapy drugs in bladder cancer.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China